First cases have been scheduled in Germany for Medovex’s DenerveX™ device for the treatment of Facet Joint Syndrome.
Medovex describes the procedure as Rotacapsulation™, combining high heat and rotational capsular tissue shaving in a minimally invasive posterior procedure.
Prior to receipt of CE Mark approval, which occurred at the end of 2Q17, Medovex had secured its German distribution partner and renewed payment coding in the region for 2017.
Sources: Medovex Corporation; ORTHOWORLD Inc.
First cases have been scheduled in Germany for Medovex's DenerveX™ device for the treatment of Facet Joint Syndrome.
Medovex describes the procedure as Rotacapsulation™, combining high heat and rotational capsular tissue shaving in a minimally invasive posterior procedure.
Prior to receipt of CE Mark approval, which occurred at the end...
First cases have been scheduled in Germany for Medovex’s DenerveX™ device for the treatment of Facet Joint Syndrome.
Medovex describes the procedure as Rotacapsulation™, combining high heat and rotational capsular tissue shaving in a minimally invasive posterior procedure.
Prior to receipt of CE Mark approval, which occurred at the end of 2Q17, Medovex had secured its German distribution partner and renewed payment coding in the region for 2017.
Sources: Medovex Corporation; ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





